Sermonix discloses 36.9% investment in LeonaBio
Sermonix Pharmaceuticals disclosed an investment in LeonaBio, Inc. with a 36.9% stake.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.